[1] Seleem M.N., Boyle S.M., Sriranganathan N., Brucellosis: a re-emerging zoonosis, Veterinary microbiology. (2010) 140:392-398.
[2] Yang Y., Yin J., Guo D., Lang X., Wang X., Immunization of mice with recombinant S-adenosyl-L-homocysteine hydrolase protein confers protection against Brucella melitensis infection, FEMS immunology and medical microbiology. (2011) 61:159-167.
[3] Onate A.A., Cespedes S., Cabrera A., Rivers R., Gonzalez A., Munoz C., Folch H., Andrews E., A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice, Infection and immunity. (2003) 71:4857-4861.
[4] Munoz-Montesino C., Andrews E., Rivers R., Gonzalez-Smith A., Moraga-Cid G., Folch H., Cespedes S., Onate A.A., Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells, Infection and immunity. (2004) 72:2081-2087.
[5] Surendran N., Hiltbold E.M., Heid B., Sriranganathan N., Boyle S.M., Zimmerman K.L., Makris M.R., Witonsky S.G., Live Brucella abortus rough vaccine strain RB51 stimulates enhanced innate immune response in vitro compared to rough vaccine strain RB51SOD and virulent smooth strain 2308 in murine bone marrow-derived dendritic cells, Veterinary microbiology. (2011) 147:75-82.
[6] Saez D., Fernandez P., Rivera A., Andrews E., Onate A., Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity, Vaccine. (2012) 30:1283-1290.
[7] Nagai Y., Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding, Rev Med Virol. (1999) 9:83-99.
[8] Billeter M.A., Naim H.Y., Udem S.A., Reverse genetics of measles virus and resulting multivalent recombinant vaccines: applications of recombinant measles viruses, Curr Top Microbiol Immunol. (2009) 329:129-162.
[9] McGettigan J.P., Foley H.D., Belyakov I.M., Berzofsky J.A., Pomerantz R.J., Schnell M.J., Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates, J Virol. (2001) 75:4430-4434.
[10] McGettigan J.P., Sarma S., Orenstein J.M., Pomerantz R.J., Schnell M.J., Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector, J Virol. (2001) 75:8724-8732.
[11] Siler C.A., McGettigan J.P., Dietzschold B., Herrine S.K., Dubuisson J., Pomerantz R.J., Schnell M.J., Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines. Virology 292:24–34. (2001).
[12] Wen Y., Wang H., Wu H., Yang F., Tripp R.A., Hogan R.J., Fu Z.F., Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination, Journal of virology. (2011) 85:1634-1644.
[13] Zhou M., Zhang G., Ren G., Gnanadurai C.W., Li Z., Chai Q., Yang Y., Leyson C.M., Wu W., Cui M., Fu Z.F., Recombinant rabies viruses expressing GM-CSF or flagellin are effective vaccines for both intramuscular and oral immunizations, PloS one. (2013) 8:e63384.
[14] Buchholz U.J., Finke S., Conzelmann K.K., Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter, J Virol. (1999) 73:251-259.
[15] Inoue K., Shoji Y., Kurane I., Iijima T., Sakai T., Morimoto K., An improved method for recovering rabies virus from cloned cDNA, J Virol Methods. (2003) 107:229-236.
[16] Takayama-Ito M., Inoue K., Shoji Y., Inoue S., Iijima T., Sakai T., Kurane I., Morimoto K., A highly attenuated rabies virus HEP-Flury strain reverts to virulent by single amino acid substitution to arginine at position 333 in glycoprotein, Virus Res. (2006) 119:208-215.
[17] Armstrong S.M., Wang C., Tigdi J., Si X., Dumpit C., Charles S., Gamage A., Moraes T.J., Lee W.L., Influenza infects lung microvascular endothelium leading to microvascular leak: role of apoptosis and claudin-5, PloS one. (2012) 7:e47323.
[18] Braniste V., Leveque M., Buisson-Brenac C., Bueno L., Fioramonti J., Houdeau E., Oestradiol decreases colonic permeability through oestrogen receptor beta-mediated up-regulation of occludin and junctional adhesion molecule-A in epithelial cells, The Journal of physiology. (2009) 587:3317-3328.
[19] Phares T.W., Kean R.B., Mikheeva T., Hooper D.C., Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system, Journal of immunology. (2006) 176:7666-7675.
[20] Smith J.S., Yager, P.A.., Baer, G.M., A rapid fluorescence focus inhibition test (RFFIT) for determining rabies virus-neutralisng antibody. In: Meslin, F.-X., Kaplan, M,M., Koprowski, H. (Eds.), Laboratory Techniques in Rabies, 4th ed. .pp. 181-192. (1996).
[21] Ioakeimidis F., Ott C., Kozjak-Pavlovic V., Violitzi F., Rinotas V., Makrinou E., Eliopoulos E., Fasseas C., Kollias G., Douni E., A Splicing Mutation in the Novel Mitochondrial Protein DNAJC11 Causes Motor Neuron Pathology Associated with Cristae Disorganization, and Lymphoid Abnormalities in Mice, PloS one. (2014) 9:e104237.
[22] Zhao L., Toriumi H., Wang H., Kuang Y., Guo X., Morimoto K., Fu Z.F., Expression of MIP-1alpha (CCL3) by a recombinant rabies virus enhances its immunogenicity by inducing innate immunity and recruiting dendritic cells and B cells, Journal of virology. (2010) 84:9642-9648.
[23] Wang H., Zhang G., Wen Y., Yang S., Xia X., Fu Z.F., Intracerebral administration of recombinant rabies virus expressing GM-CSF prevents the development of rabies after infection with street virus, PloS one. (2011) 6:e25414.
[24] Retamal-Diaz A., Riquelme-Neira R., Saez D., Rivera A., Fernandez P., Cabrera A., Guzman C.A., Onate A., Use of S-[2,3-bispalmitoyiloxy-(2R)-propyl]-R-cysteinyl-amido- monomethoxy polyethylene glycol as an adjuvant improved protective immunity associated with a DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus in mice, Clinical and vaccine immunology : CVI. (2014) 21:1474-1480.
[25] Singha H., Mallick A.I., Jana C., Isore D.P., Goswami T.K., Srivastava S.K., Azevedo V.A., Chaudhuri P., Owais M., Escheriosomes entrapped DNA vaccine co-expressing Cu-Zn superoxide dismutase and IL-18 confers protection against Brucella abortus, Microbes and infection / Institut Pasteur. (2008) 10:1089-1096.
[26] Yu D.H., Hu X.D., Cai H., A combined DNA vaccine encoding BCSP31, SOD, and L7/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses, DNA and cell biology. (2007) 26:435-443.